Larry Kessler, Sc.D. is Professor in the Department of Health Systems and Population Health, University of Washington School of Public Health. He has over 40 years of experience in health services research. He came to the University of Washington from the U.S. Food and Drug Administration where he served as the director of both the Office of Surveillance and Biometrics and Office of Science and Engineering Laboratories at FDA’s Center for Devices and Radiological Health. Prior to that, his work in cancer surveillance with the Applied Research Branch at NCI substantially changed how cancer surveillance is performed, with the addition of the Cancer supplements to the National Health Interview Survey, the SEER-Medicare data system, and the Breast Cancer Screening and Surveillance Consortiums. He also spent 6 years at the National Institute of Mental Health primarily doing research on the diagnosis and prevalence of mental disorders in primary care. He has an extensive research record in applied health services research with work in cancer, in cancer surveillance research, and regulatory knowledge of medical products, including over 200 peer-reviewed journal publications. His recent research has broadened this into related fields of comparative effectiveness, patient centered and outcomes research.His recent work has focused on use of technologies in medical care. He is currently involved with several randomized trials and observational studies of comparative effectiveness and patient-centered outcomes research. He also has particular research and expertise in diagnostic technologies. He now serves as Deputy Chair of the Multi-Cancer Early Detection Consortium.
Professor Larry Kessler, Professor of Health Systems and Population Health
Biography
Session title
Keynote speech: Challenges and opportunities in using personalised medicine and artificial intelligence for the early detection of cancer
Session title
Panel session: Driving change using the triple helix model of innovation - how can government, industry and academia collaborate to improve cancer health outcomes?